138 related articles for article (PubMed ID: 12517441)
21. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
Sen G; Flora M; Chattopadhyay G; Klinman DM; Lees A; Mond JJ; Snapper CM
Cell Immunol; 2004; 232(1-2):64-74. PubMed ID: 15922717
[TBL] [Abstract][Full Text] [Related]
22. Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties.
Bianco A; Hoebeke J; Godefroy S; Chaloin O; Pantarotto D; Briand JP; Muller S; Prato M; Partidos CD
J Am Chem Soc; 2005 Jan; 127(1):58-9. PubMed ID: 15631447
[TBL] [Abstract][Full Text] [Related]
23. Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials.
Lee SW; Song MK; Baek KH; Park Y; Kim JK; Lee CH; Cheong HK; Cheong C; Sung YC
J Immunol; 2000 Oct; 165(7):3631-9. PubMed ID: 11034366
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the development of immunostimulatory oligonucleotides.
Uhlmann E; Vollmer J
Curr Opin Drug Discov Devel; 2003 Mar; 6(2):204-17. PubMed ID: 12669456
[TBL] [Abstract][Full Text] [Related]
25. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.
Hartmann G; Weeratna RD; Ballas ZK; Payette P; Blackwell S; Suparto I; Rasmussen WL; Waldschmidt M; Sajuthi D; Purcell RH; Davis HL; Krieg AM
J Immunol; 2000 Feb; 164(3):1617-24. PubMed ID: 10640783
[TBL] [Abstract][Full Text] [Related]
26. Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle.
Chu CY; Lee SC; Liu SS; Lin YM; Shen PC; Yu C; Lee KH; Zhao X; Lee JW
Nucleic Acid Ther; 2011 Oct; 21(5):323-32. PubMed ID: 21916610
[TBL] [Abstract][Full Text] [Related]
27. Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis.
Sparwasser T; Hültner L; Koch ES; Luz A; Lipford GB; Wagner H
J Immunol; 1999 Feb; 162(4):2368-74. PubMed ID: 9973517
[TBL] [Abstract][Full Text] [Related]
28. Novel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cells.
Marshall JD; Hessel EM; Gregorio J; Abbate C; Yee P; Chu M; Van Nest G; Coffman RL; Fearon KL
Nucleic Acids Res; 2003 Sep; 31(17):5122-33. PubMed ID: 12930963
[TBL] [Abstract][Full Text] [Related]
29. CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.
van Ojik HH; Bevaart L; Dahle CE; Bakker A; Jansen MJ; van Vugt MJ; van de Winkel JG; Weiner GJ
Cancer Res; 2003 Sep; 63(17):5595-600. PubMed ID: 14500400
[TBL] [Abstract][Full Text] [Related]
30. Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3' sequence modifications.
Zimmermann S; Heeg K; Dalpke A
Vaccine; 2003 Feb; 21(9-10):990-5. PubMed ID: 12547613
[TBL] [Abstract][Full Text] [Related]
31. Immunostimulatory CpG-DNA activates murine microglia.
Dalpke AH; Schäfer MK; Frey M; Zimmermann S; Tebbe J; Weihe E; Heeg K
J Immunol; 2002 May; 168(10):4854-63. PubMed ID: 11994434
[TBL] [Abstract][Full Text] [Related]
32. Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides.
Kamstrup S; Verthelyi D; Klinman DM
Vet Microbiol; 2001 Feb; 78(4):353-62. PubMed ID: 11182501
[TBL] [Abstract][Full Text] [Related]
33. Bis-4-aminoquinolines: novel triple-helix DNA intercalators and antagonists of immunostimulatory CpG-oligodeoxynucleotides.
Strekowski L; Say M; Zegrocka O; Tanious FA; Wilson WD; Manzel L; Macfarlane DE
Bioorg Med Chem; 2003 Mar; 11(6):1079-85. PubMed ID: 12614895
[TBL] [Abstract][Full Text] [Related]
34. The influence of base sequence on the immunostimulatory properties of DNA.
Pisetsky DS
Immunol Res; 1999; 19(1):35-46. PubMed ID: 10374694
[TBL] [Abstract][Full Text] [Related]
35. CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses.
Yeh DW; Lai CY; Liu YL; Lu CH; Tseng PH; Yuh CH; Yu GY; Liu SJ; Leng CH; Chuang TH
Sci Rep; 2017 Dec; 7(1):17297. PubMed ID: 29229937
[TBL] [Abstract][Full Text] [Related]
36. Effect of suppressive DNA on CpG-induced immune activation.
Yamada H; Gursel I; Takeshita F; Conover J; Ishii KJ; Gursel M; Takeshita S; Klinman DM
J Immunol; 2002 Nov; 169(10):5590-4. PubMed ID: 12421936
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant activity of CpG oligodeoxynucleotides.
Klinman DM
Int Rev Immunol; 2006; 25(3-4):135-54. PubMed ID: 16818369
[TBL] [Abstract][Full Text] [Related]
38. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells.
Zhu FG; Marshall JS
J Leukoc Biol; 2001 Feb; 69(2):253-62. PubMed ID: 11272276
[TBL] [Abstract][Full Text] [Related]
39. Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs.
Zhao H; Cheng SH; Yew NS
Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):381-9. PubMed ID: 11079577
[TBL] [Abstract][Full Text] [Related]
40. 'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents.
Yu D; Kandimalla ER; Bhagat L; Tang JY; Cong Y; Tang J; Agrawal S
Nucleic Acids Res; 2002 Oct; 30(20):4460-9. PubMed ID: 12384593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
